Why the study?
Does a single measurement of NT-proBNP predict mortality better than LVEF, VO2, or HFSS in patients with advanced CHF?
Population
Patients with advanced congestive heart failure (CHF)
Comparison
Single measurement of NT-proBNP vs LVEF, VO2, or HFSS
Design
Cohort
Authors
Loading...
May better stratify mortality risk in advanced HF than LVEF, VO2, or HFSS; hypothesis-generating and requires prospective validation before practice change.
Does a single measurement of NT-proBNP predict mortality better than LVEF, VO2, or HFSS in patients with advanced CHF?
A single NT-proBNP measurement is a superior prognostic marker for mortality in advanced heart failure compared to traditional metrics like LVEF, VO2, and HFSS.
R Gardner (2003) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: